1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 Clore, G.M. Powers, B. Garrett, D.S. Gronenborn, A.M. http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic 1 90.00 90.00 90.00 1.000 1.000 1.000 C3 H7 N O2 89.093 y ALANINE L-peptide linking C6 H15 N4 O2 1 175.209 y ARGININE L-peptide linking C4 H8 N2 O3 132.118 y ASPARAGINE L-peptide linking C4 H7 N O4 133.103 y ASPARTIC ACID L-peptide linking C3 H7 N O2 S 121.158 y CYSTEINE L-peptide linking C5 H10 N2 O3 146.144 y GLUTAMINE L-peptide linking C5 H9 N O4 147.129 y GLUTAMIC ACID L-peptide linking C2 H5 N O2 75.067 y GLYCINE peptide linking C6 H10 N3 O2 1 156.162 y HISTIDINE L-peptide linking C6 H13 N O2 131.173 y ISOLEUCINE L-peptide linking C6 H13 N O2 131.173 y LEUCINE L-peptide linking C6 H15 N2 O2 1 147.195 y LYSINE L-peptide linking C5 H11 N O2 S 149.211 y METHIONINE L-peptide linking C9 H11 N O2 165.189 y PHENYLALANINE L-peptide linking C5 H9 N O2 115.130 y PROLINE L-peptide linking C3 H7 N O3 105.093 y SERINE L-peptide linking C4 H9 N O3 119.119 y THREONINE L-peptide linking C11 H12 N2 O2 204.225 y TRYPTOPHAN L-peptide linking C9 H11 N O3 181.189 y TYROSINE L-peptide linking C5 H11 N O2 117.146 y VALINE L-peptide linking US Biochemistry BICHAW 0033 0006-2960 32 6744 6762 10.1021/bi00077a030 8329398 The high-resolution, three-dimensional solution structure of human interleukin-4 determined by multidimensional heteronuclear magnetic resonance spectroscopy. 1993 US Science SCIEAS 0038 0036-8075 256 1673 Three-Dimensional Solution Structure of Human Interleukin-4 by Multidimensional Heteronuclear Magnetic Resonance Spectroscopy 1992 US Biochemistry BICHAW 0033 0006-2960 31 4334 1H, 15N, 13C and 13Co Assignments of Human Interleukin-4 Using Three Dimensional Double-and Triple-Resonance Heteronuclear Magnetic Resonance Spectroscopy 1992 US Biochemistry BICHAW 0033 0006-2960 31 4347 Determination of the Secondary Structure and Folding Topology of Human Interleukin-4 Using Three-Dimensional Heteronuclear Magnetic Resonance Spectroscopy 1992 10.2210/pdb1iti/pdb pdb_00001iti 1.000000 0.000000 0.000000 0.000000 1.000000 0.000000 0.000000 0.000000 1.000000 0.00000 0.00000 0.00000 15391.601 INTERLEUKIN-4 1 man polymer no no EAEAHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKDTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRH KQLIRFLKRLDRNLWGLAGLNSCPVKEADQSTLENFLERLKTIMREKYSKCSS EAEAHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKDTTEKETFCRAATVLRQFYSHHEKDTRCLGATAQQFHRH KQLIRFLKRLDRNLWGLAGLNSCPVKEADQSTLENFLERLKTIMREKYSKCSS A polypeptide(L) n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n n human Homo sample POTENTIAL 9606 Homo sapiens database_2 pdbx_database_status pdbx_struct_assembly pdbx_struct_oper_list struct_ref_seq_dif repository Initial release Version format compliance Version format compliance Database references Derived calculations Other 1 0 1993-07-15 1 1 2008-03-24 1 2 2011-07-13 1 3 2022-02-23 _database_2.pdbx_DOI _database_2.pdbx_database_accession _pdbx_database_status.process_site _struct_ref_seq_dif.details Y BNL 1993-04-12 REL THE NUMBERING SCHEME IN THIS STRUCTURE INCLUDES THE FOUR-RESIDUE SEQUENCE GLU-ALA-GLU-ALA AT THE N-TERMINUS OF THE RECOMBINANT PROTEIN WHICH IS NOT PART OF THE NATURAL HUMAN IL-4; THE NATURAL IL-4 SEQUENCE THEREFORE STARTS AT RESIDUE 5. THE TWO POTENTIAL N-LINKED GLYCOSYLATION SITES AT ASN 42 AND ASN 109 IN THE NATURAL SEQUENCE WERE CHANGED TO ASP TO PREVENT HYPERGLYCOSYLATION IN THE YEAST HOST. 31 DETAILS OF THE STRUCTURE DETERMINATION AND ALL STRUCTURAL STATISTICS ARE GIVEN IN THE REFERENCE LISTED ON THE JRNL RECORDS ABOVE (I.E. AGREEMENT WITH EXPERIMENTAL RESTRAINTS, DEVIATIONS FROM IDEALITY FOR BOND LENGTHS, ANGLES, PLANES AND CHIRALITY, NON-BONDED CONTACTS, ATOMIC RMS DIFFERENCES BETWEEN THE CALCULATED STRUCTURES). THE STRUCTURES ARE BASED ON A TOTAL OF 2973 EXPERIMENTAL NMR RESTRAINTS COMPRISING: 2515 INTERPROTON DISTANCE RESTRAINTS DERIVED FROM NOE MEASUREMENTS; 102 HYDROGEN-BONDING DISTANCE RESTRAINTS FOR 51 HYDROGEN-BONDS IDENTIFIED ON THE BASIS OF THE NOE AND AMIDE PROTON EXCHANGE DATA, AS WELL AS THE INITIAL STRUCTURE CALCULATIONS; AND 130 PHI, 119 PSI, 73 CHI1, 32 CHI2 AND 2 CHI3 TORSION ANGLE RESTRAINTS DERIVED FROM COUPLING CONSTANTS, NOE DATA, AND 13C SECONDARY CHEMICAL SHIFTS. THE METHOD USED TO DETERMINE THE STRUCTURES IS THE HYBRID METRIC MATRIX DISTANCE GEOMETRY-DYNAMICAL SIMULATED ANNEALING METHOD [NILGES, M., CLORE, G.M. & GRONENBORN, A.M., FEBS LETT. 229, 317-324 (1988)]. A TOTAL OF 30 STRUCTURES WERE CALCULATED. THE ATOMIC RMS DISTRIBUTION ABOUT THE MEAN COORDINATE POSITIONS FOR RESIDUES 8 - 129 IS 0.44 (+/-0.03) ANGSTROMS FOR THE BACKBONE ATOMS, 0.83 (+/-0.03) ANGSTROMS FOR ALL ATOMS, AND 0.51 (+/-0.04) ANGSTROMS FOR ALL ATOMS EXCLUDING DISORDERED SIDE CHAINS. THE N- (RESIDUES 1 - 7) AND C- (RESIDUES 130 - 133) TERMINAL RESIDUES ARE DISORDERED. THE COORDINATES OF THE RESTRAINED MINIMIZED STRUCTURE ARE LISTED FIRST AS MODEL 0. THIS (SA)R RESTRAINED MINIMIZED MEAN STRUCTURE WAS DERIVED BY AVERAGING THE COORDINATES OF THE INDIVIDUAL SA STRUCTURES (BEST FITTED TO RESIDUES 8 - 129) AND SUBJECTING THE RESULTING COORDINATES TO RESTRAINED MINIMIZATION. THE QUANTITY PRESENTED IN THE TEMPERATURE FACTOR FIELD (COLUMNS 61 - 66) REPRESENTS THE ATOMIC RMS DEVIATIONS OF THE 30 INDIVIDUAL SA STRUCTURES ABOUT THE MEAN STRUCTURE. RESIDUES 1 - 7 AND 130 - 133 AT THE N- AND C-TERMINI, RESPECTIVELY, ARE DISORDERED. GLU 1 n 1 GLU 1 A ALA 2 n 2 ALA 2 A GLU 3 n 3 GLU 3 A ALA 4 n 4 ALA 4 A HIS 5 n 5 HIS 5 A LYS 6 n 6 LYS 6 A CYS 7 n 7 CYS 7 A ASP 8 n 8 ASP 8 A ILE 9 n 9 ILE 9 A THR 10 n 10 THR 10 A LEU 11 n 11 LEU 11 A GLN 12 n 12 GLN 12 A GLU 13 n 13 GLU 13 A ILE 14 n 14 ILE 14 A ILE 15 n 15 ILE 15 A LYS 16 n 16 LYS 16 A THR 17 n 17 THR 17 A LEU 18 n 18 LEU 18 A ASN 19 n 19 ASN 19 A SER 20 n 20 SER 20 A LEU 21 n 21 LEU 21 A THR 22 n 22 THR 22 A GLU 23 n 23 GLU 23 A GLN 24 n 24 GLN 24 A LYS 25 n 25 LYS 25 A THR 26 n 26 THR 26 A LEU 27 n 27 LEU 27 A CYS 28 n 28 CYS 28 A THR 29 n 29 THR 29 A GLU 30 n 30 GLU 30 A LEU 31 n 31 LEU 31 A THR 32 n 32 THR 32 A VAL 33 n 33 VAL 33 A THR 34 n 34 THR 34 A ASP 35 n 35 ASP 35 A ILE 36 n 36 ILE 36 A PHE 37 n 37 PHE 37 A ALA 38 n 38 ALA 38 A ALA 39 n 39 ALA 39 A SER 40 n 40 SER 40 A LYS 41 n 41 LYS 41 A ASP 42 n 42 ASP 42 A THR 43 n 43 THR 43 A THR 44 n 44 THR 44 A GLU 45 n 45 GLU 45 A LYS 46 n 46 LYS 46 A GLU 47 n 47 GLU 47 A THR 48 n 48 THR 48 A PHE 49 n 49 PHE 49 A CYS 50 n 50 CYS 50 A ARG 51 n 51 ARG 51 A ALA 52 n 52 ALA 52 A ALA 53 n 53 ALA 53 A THR 54 n 54 THR 54 A VAL 55 n 55 VAL 55 A LEU 56 n 56 LEU 56 A ARG 57 n 57 ARG 57 A GLN 58 n 58 GLN 58 A PHE 59 n 59 PHE 59 A TYR 60 n 60 TYR 60 A SER 61 n 61 SER 61 A HIS 62 n 62 HIS 62 A HIS 63 n 63 HIS 63 A GLU 64 n 64 GLU 64 A LYS 65 n 65 LYS 65 A ASP 66 n 66 ASP 66 A THR 67 n 67 THR 67 A ARG 68 n 68 ARG 68 A CYS 69 n 69 CYS 69 A LEU 70 n 70 LEU 70 A GLY 71 n 71 GLY 71 A ALA 72 n 72 ALA 72 A THR 73 n 73 THR 73 A ALA 74 n 74 ALA 74 A GLN 75 n 75 GLN 75 A GLN 76 n 76 GLN 76 A PHE 77 n 77 PHE 77 A HIS 78 n 78 HIS 78 A ARG 79 n 79 ARG 79 A HIS 80 n 80 HIS 80 A LYS 81 n 81 LYS 81 A GLN 82 n 82 GLN 82 A LEU 83 n 83 LEU 83 A ILE 84 n 84 ILE 84 A ARG 85 n 85 ARG 85 A PHE 86 n 86 PHE 86 A LEU 87 n 87 LEU 87 A LYS 88 n 88 LYS 88 A ARG 89 n 89 ARG 89 A LEU 90 n 90 LEU 90 A ASP 91 n 91 ASP 91 A ARG 92 n 92 ARG 92 A ASN 93 n 93 ASN 93 A LEU 94 n 94 LEU 94 A TRP 95 n 95 TRP 95 A GLY 96 n 96 GLY 96 A LEU 97 n 97 LEU 97 A ALA 98 n 98 ALA 98 A GLY 99 n 99 GLY 99 A LEU 100 n 100 LEU 100 A ASN 101 n 101 ASN 101 A SER 102 n 102 SER 102 A CYS 103 n 103 CYS 103 A PRO 104 n 104 PRO 104 A VAL 105 n 105 VAL 105 A LYS 106 n 106 LYS 106 A GLU 107 n 107 GLU 107 A ALA 108 n 108 ALA 108 A ASP 109 n 109 ASP 109 A GLN 110 n 110 GLN 110 A SER 111 n 111 SER 111 A THR 112 n 112 THR 112 A LEU 113 n 113 LEU 113 A GLU 114 n 114 GLU 114 A ASN 115 n 115 ASN 115 A PHE 116 n 116 PHE 116 A LEU 117 n 117 LEU 117 A GLU 118 n 118 GLU 118 A ARG 119 n 119 ARG 119 A LEU 120 n 120 LEU 120 A LYS 121 n 121 LYS 121 A THR 122 n 122 THR 122 A ILE 123 n 123 ILE 123 A MET 124 n 124 MET 124 A ARG 125 n 125 ARG 125 A GLU 126 n 126 GLU 126 A LYS 127 n 127 LYS 127 A TYR 128 n 128 TYR 128 A SER 129 n 129 SER 129 A LYS 130 n 130 LYS 130 A CYS 131 n 131 CYS 131 A SER 132 n 132 SER 132 A SER 133 n 133 SER 133 A author_defined_assembly 1 monomeric 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 0.0000000000 0.0000000000 0.0000000000 1.0000000000 1_555 x,y,z identity operation 0.0000000000 0.0000000000 0.0000000000 A N VAL 33 A N VAL 33 A O SER 111 A O SER 111 2 A A H HZ1 ASP LYS 8 130 1.30 6 A A H HZ3 ASP LYS 8 130 1.34 8 A A HG H SER SER 132 133 1.33 9 A A HG1 H THR GLN 73 76 1.31 10 A A H1 H GLU ALA 1 2 1.31 17 A A HG1 H THR CYS 26 28 1.31 18 A A HH11 HD22 ARG ASN 89 93 1.31 1 A ALA 2 -51.80 -105.33 1 A ALA 4 -169.16 -23.58 1 A LYS 6 -67.08 25.26 1 A ALA 39 -157.69 43.39 1 A LYS 41 -130.05 -81.90 1 A LYS 46 -52.72 -70.26 1 A PHE 59 -83.19 -70.94 1 A ARG 68 -100.25 -61.24 1 A ALA 72 -138.47 -30.58 1 A ARG 89 -83.71 -71.92 1 A TRP 95 -56.86 -8.61 1 A CYS 103 -160.33 65.71 1 A LYS 106 -103.52 -130.13 1 A ASP 109 -83.63 -105.43 1 A GLU 114 -68.45 -74.83 1 A TYR 128 -65.42 7.34 1 A LYS 130 -156.61 -124.34 1 A SER 132 -105.38 74.13 2 A ALA 4 -159.04 -147.99 2 A ALA 38 -77.30 27.89 2 A ALA 39 -147.75 10.52 2 A SER 40 -55.62 105.52 2 A LYS 41 -145.18 -89.72 2 A GLU 64 -47.27 -16.95 2 A THR 67 -93.13 43.17 2 A ARG 68 -95.76 -62.18 2 A ALA 72 -147.37 -35.25 2 A THR 73 -48.11 164.19 2 A ARG 89 -90.09 -77.63 2 A LEU 94 -58.35 -71.01 2 A TRP 95 -48.54 -14.19 2 A LEU 97 -59.83 -1.43 2 A ALA 98 -81.88 -73.85 2 A ASN 101 -87.66 -88.62 2 A CYS 103 -159.34 68.20 2 A LYS 106 -92.70 -106.85 2 A ALA 108 179.37 172.99 2 A ASP 109 -92.59 -120.54 2 A LYS 130 -175.28 -115.44 2 A SER 132 -147.56 56.59 3 A GLN 12 -78.94 -71.00 3 A ALA 39 -165.01 89.93 3 A LYS 41 -145.70 -70.63 3 A PHE 59 -83.56 -70.24 3 A GLU 64 -47.58 -18.94 3 A THR 67 -95.69 37.83 3 A ARG 68 -93.77 -70.42 3 A LEU 70 -94.52 -66.00 3 A ARG 89 -76.07 -70.08 3 A LEU 97 -59.06 -2.23 3 A ALA 98 -90.03 -77.92 3 A ASN 101 -69.48 -77.84 3 A LYS 106 -92.84 -130.32 3 A ALA 108 169.96 168.44 3 A ASP 109 -93.10 -104.73 3 A GLU 114 -64.54 -75.66 3 A TYR 128 -69.59 10.45 3 A LYS 130 -170.19 -149.78 3 A CYS 131 -47.50 -15.68 3 A SER 132 -89.58 36.06 4 A LEU 11 -48.74 -16.98 4 A LYS 25 -150.84 84.11 4 A CYS 28 -58.00 -7.60 4 A GLU 30 -67.25 6.52 4 A ILE 36 -146.81 -34.86 4 A ALA 39 -161.98 37.36 4 A ASP 42 -148.12 29.02 4 A THR 44 -60.67 -166.47 4 A THR 67 -94.12 40.82 4 A ARG 89 -85.28 -75.07 4 A LEU 94 -57.10 -70.82 4 A TRP 95 -51.62 -9.60 4 A LEU 97 -59.77 -1.54 4 A ALA 98 -82.42 -70.84 4 A CYS 103 -165.09 68.43 4 A LYS 106 -142.27 -127.46 4 A ALA 108 -171.66 -143.44 4 A ASP 109 -92.59 -142.29 4 A GLU 114 -68.84 -75.34 4 A LYS 130 -171.18 -150.36 5 A GLU 3 -155.48 -1.46 5 A ALA 4 -155.45 72.54 5 A LYS 6 -147.48 19.82 5 A CYS 28 -65.04 2.28 5 A ASP 35 -49.15 175.34 5 A ILE 36 -146.56 -35.09 5 A ALA 39 -154.70 11.88 5 A LYS 41 -149.11 -80.48 5 A PHE 59 -84.73 -70.29 5 A HIS 62 -90.05 -61.34 5 A THR 67 -76.12 40.04 5 A ALA 72 -147.61 -35.29 5 A THR 73 -49.59 164.43 5 A LEU 94 -59.06 -73.91 5 A TRP 95 -47.43 -16.33 5 A ASN 101 -88.04 -94.42 5 A CYS 103 -164.88 68.06 5 A LYS 106 -92.54 -129.91 5 A ALA 108 170.03 130.33 5 A ASP 109 -72.90 -118.41 5 A GLU 114 -76.18 -76.34 5 A TYR 128 -68.34 8.44 5 A SER 129 -90.00 51.96 5 A LYS 130 -92.48 -111.91 6 A GLU 3 -140.99 -21.35 6 A LEU 31 -62.08 -169.98 6 A ASP 35 -47.65 171.12 6 A ILE 36 -147.21 -34.50 6 A ALA 39 -151.04 -10.01 6 A LYS 41 -146.70 -39.65 6 A ASP 42 -148.71 16.55 6 A THR 44 -77.37 -147.94 6 A THR 67 -91.25 45.41 6 A ARG 89 -90.08 -65.78 6 A TRP 95 -55.69 -9.96 6 A LEU 97 -59.57 -1.53 6 A CYS 103 -164.94 68.25 6 A LYS 106 -144.39 -131.40 6 A ALA 108 -172.14 -140.09 6 A ASP 109 -92.88 -122.30 6 A GLU 114 -70.14 -75.00 6 A GLU 118 -70.71 -70.09 6 A SER 129 -73.69 20.53 6 A LYS 130 -59.06 -110.78 7 A ALA 4 -177.70 -7.60 7 A LEU 11 -48.42 -15.37 7 A THR 26 -92.95 -155.25 7 A ILE 36 -146.99 -34.85 7 A ALA 39 -157.46 14.90 7 A LYS 41 -147.45 -76.99 7 A PHE 59 -84.40 -74.14 7 A THR 67 -75.58 36.32 7 A ALA 72 -101.08 -67.00 7 A THR 73 -49.41 176.17 7 A ARG 89 -87.43 -71.61 7 A TRP 95 -56.07 -5.60 7 A LEU 97 -59.64 -1.21 7 A ASN 101 -92.43 -63.49 7 A CYS 103 -162.84 68.05 7 A LYS 106 -92.51 -130.07 7 A ALA 108 174.92 153.13 7 A ASP 109 -92.26 -116.98 7 A GLU 114 -71.56 -72.25 7 A LYS 130 -178.51 -106.71 7 A SER 132 -153.34 72.43 8 A GLU 3 -64.20 2.82 8 A LYS 25 -150.80 88.74 8 A ILE 36 -147.39 -35.07 8 A ALA 39 -148.33 34.10 8 A LYS 41 -86.99 -89.94 8 A ARG 57 -62.10 -70.17 8 A PHE 59 -85.08 -76.63 8 A THR 67 -90.40 45.05 8 A ARG 68 -95.80 -60.15 8 A ALA 72 -148.27 -35.85 8 A THR 73 -57.34 176.08 8 A ARG 89 -90.07 -77.53 8 A LEU 97 -59.46 -1.95 8 A ASN 101 -93.00 -90.92 8 A CYS 103 -164.91 68.12 8 A LYS 106 -85.66 -107.17 8 A ASP 109 -92.55 -110.22 8 A GLU 114 -72.91 -76.90 8 A TYR 128 -69.27 10.01 8 A LYS 130 -165.59 -150.80 8 A SER 132 -95.68 -155.45 9 A ALA 2 -157.02 -91.95 9 A GLU 3 -141.74 -72.99 9 A ALA 4 -91.13 -99.49 9 A HIS 5 -60.57 -156.25 9 A LYS 6 -147.55 52.23 9 A LYS 25 -151.16 85.73 9 A GLU 30 -49.68 -13.91 9 A ILE 36 -145.89 -33.56 9 A SER 40 -57.97 83.43 9 A ASP 42 -147.98 59.92 9 A LYS 46 -46.96 -75.18 9 A PHE 59 -85.10 -74.20 9 A GLU 64 -47.27 -19.24 9 A THR 67 -78.46 29.89 9 A ARG 68 -93.37 -68.82 9 A CYS 69 -65.07 0.90 9 A ALA 72 -147.03 -36.28 9 A LEU 97 -59.78 -1.51 9 A ALA 98 -82.08 -74.00 9 A ASN 101 -92.79 -62.54 9 A CYS 103 -153.48 67.78 9 A LYS 106 -144.55 -130.11 9 A ALA 108 169.96 161.07 9 A ASP 109 -76.41 -142.50 9 A GLU 114 -69.30 -73.37 9 A SER 129 -74.41 31.32 9 A LYS 130 -75.01 -99.79 10 A CYS 28 -66.82 2.05 10 A GLU 30 -55.96 -5.78 10 A ALA 39 -163.83 88.37 10 A ASP 42 -147.85 21.58 10 A THR 44 -70.43 -169.73 10 A PHE 59 -82.93 -75.78 10 A THR 67 -81.39 42.30 10 A CYS 103 -165.06 68.20 10 A LYS 106 -142.09 -131.33 10 A ALA 108 170.11 -174.07 10 A ASP 109 -67.24 -148.18 10 A GLU 114 -69.30 -71.10 10 A TYR 128 -69.88 1.40 10 A LYS 130 -162.28 -130.33 11 A ALA 2 -177.51 53.17 11 A GLU 3 -154.11 -20.79 11 A ILE 36 -147.18 -35.06 11 A ALA 39 -156.22 49.77 11 A LYS 41 -92.57 -81.73 11 A PHE 59 -84.23 -70.66 11 A GLU 64 -47.43 -15.61 11 A THR 67 -100.31 47.54 11 A ARG 68 -100.16 -77.19 11 A CYS 69 -52.50 -7.84 11 A ARG 89 -90.09 -70.04 11 A TRP 95 -47.97 -14.89 11 A LEU 97 -59.93 -1.56 11 A ALA 98 -82.05 -70.17 11 A ASN 101 -92.62 -69.55 11 A CYS 103 -164.31 67.97 11 A LYS 106 -145.74 -129.98 11 A ALA 108 170.19 134.56 11 A ASP 109 -61.56 -147.05 11 A GLU 114 -70.65 -77.55 11 A LYS 130 -168.94 -133.12 11 A SER 132 -87.04 36.09 12 A ALA 2 -81.20 -152.43 12 A ALA 4 -147.60 -94.31 12 A HIS 5 -59.26 179.53 12 A LYS 6 -144.38 15.96 12 A LEU 31 -59.89 -170.27 12 A ALA 39 -155.58 28.66 12 A LYS 41 -147.50 -89.70 12 A PHE 59 -83.28 -73.55 12 A THR 67 -95.53 41.98 12 A ARG 68 -94.89 -63.96 12 A LEU 70 -94.55 -66.68 12 A TRP 95 -53.63 -9.10 12 A LEU 97 -59.76 -1.37 12 A ALA 98 -79.29 -71.47 12 A ASN 101 -89.92 -78.82 12 A CYS 103 -165.01 68.10 12 A LYS 106 -92.67 -130.09 12 A ALA 108 -152.24 -144.81 12 A ASP 109 -91.24 -134.35 12 A GLU 114 -67.63 -76.50 12 A GLU 118 -62.91 -70.11 12 A LYS 130 -147.85 -118.88 13 A ALA 4 -148.83 -29.02 13 A CYS 28 -66.42 1.49 13 A ILE 36 -147.34 -35.42 13 A ALA 39 -162.01 47.71 13 A LYS 41 -92.77 -85.10 13 A HIS 62 -90.27 -60.03 13 A THR 67 -76.62 41.19 13 A ALA 72 -146.92 -35.16 13 A ARG 89 -86.48 -74.03 13 A TRP 95 -57.32 -4.34 13 A LEU 97 -59.76 -1.53 13 A ALA 98 -81.66 -73.27 13 A ASN 101 -72.28 -70.88 13 A CYS 103 -164.96 68.24 13 A LYS 106 -82.43 -130.00 13 A ALA 108 -163.24 -163.43 13 A ASP 109 -92.67 -121.47 13 A TYR 128 -62.39 0.86 13 A LYS 130 -174.18 -105.29 13 A SER 132 -95.70 -155.48 14 A ALA 4 -176.90 44.02 14 A ALA 39 -164.99 46.25 14 A LYS 41 -91.99 -89.99 14 A THR 43 -51.19 -179.97 14 A THR 67 -92.03 44.33 14 A ARG 68 -94.54 -62.21 14 A ALA 72 -147.28 -35.78 14 A ARG 89 -76.50 -70.60 14 A LEU 97 -59.98 -1.70 14 A ALA 98 -85.59 -75.65 14 A ASN 101 -78.17 -78.77 14 A CYS 103 -165.04 68.15 14 A LYS 106 -92.74 -130.14 14 A ALA 108 171.47 149.83 14 A ASP 109 -92.67 -100.37 14 A GLU 114 -58.07 -70.71 14 A TYR 128 -69.31 10.22 14 A LYS 130 -64.64 -126.16 14 A CYS 131 -64.88 3.89 14 A SER 132 -95.33 -155.40 15 A LYS 6 -92.59 41.59 15 A LEU 11 -47.62 -19.11 15 A GLN 12 -78.76 -70.30 15 A ILE 36 -150.93 -35.30 15 A ALA 39 -158.21 29.40 15 A LYS 41 -92.47 -89.88 15 A LYS 46 -60.91 -70.48 15 A THR 67 -93.55 45.40 15 A ALA 72 -146.52 -35.16 15 A LYS 88 -49.51 -18.51 15 A ARG 89 -90.14 -77.48 15 A TRP 95 -47.37 -19.44 15 A ASN 101 -120.04 -75.64 15 A CYS 103 -154.60 68.01 15 A LYS 106 -141.46 -91.82 15 A ALA 108 171.08 151.55 15 A ASP 109 -61.74 -121.11 15 A GLU 114 -71.27 -75.48 15 A TYR 128 -69.53 8.82 15 A SER 129 -54.40 -80.72 15 A LYS 130 36.86 -143.34 16 A ALA 4 -148.79 -17.05 16 A LYS 6 -158.82 13.76 16 A GLN 12 -80.93 -70.59 16 A ALA 39 -164.95 89.75 16 A PHE 59 -85.17 -74.73 16 A THR 67 -93.04 39.33 16 A LEU 70 -95.83 -109.46 16 A ALA 72 -174.46 -31.09 16 A LEU 97 -59.59 -1.44 16 A CYS 103 -164.54 68.12 16 A LYS 106 -92.12 -130.08 16 A ALA 108 -156.34 -157.99 16 A ASP 109 -92.83 -118.08 16 A GLU 114 -68.39 -75.38 16 A LYS 130 -156.58 -102.77 17 A ALA 4 -92.65 41.65 17 A LYS 6 -147.47 15.87 17 A LEU 31 -59.89 -169.88 17 A ILE 36 -145.09 -34.36 17 A LYS 41 -88.12 -71.60 17 A PHE 59 -82.12 -71.44 17 A HIS 62 -90.22 -62.53 17 A THR 67 -93.21 41.62 17 A ALA 72 -172.32 -31.34 17 A THR 73 -47.25 166.63 17 A ARG 89 -84.59 -75.16 17 A LEU 97 -59.43 -1.89 17 A ASN 101 -92.82 -68.37 17 A CYS 103 -164.97 68.08 17 A LYS 106 -141.21 -126.93 17 A ALA 108 -167.60 -155.35 17 A ASP 109 -92.75 -130.75 17 A GLU 114 -60.62 -73.36 17 A LYS 130 -169.18 -151.45 17 A CYS 131 -47.32 -19.27 17 A SER 132 -92.64 36.82 18 A ALA 2 -158.04 2.27 18 A ILE 36 -145.36 -34.76 18 A ALA 39 -158.70 27.39 18 A LYS 41 -92.58 -90.08 18 A THR 44 -80.96 -142.44 18 A PHE 59 -82.87 -78.82 18 A GLU 64 -47.49 -15.39 18 A THR 67 -95.20 32.59 18 A ARG 68 -92.27 -73.06 18 A CYS 69 -58.38 -4.21 18 A ALA 72 -147.37 -35.07 18 A THR 73 -49.07 165.70 18 A LEU 97 -59.63 -1.33 18 A ALA 98 -77.95 -71.50 18 A ASN 101 -80.83 -76.77 18 A CYS 103 -164.89 68.28 18 A LYS 106 -87.83 -103.87 18 A ALA 108 178.87 164.18 18 A ASP 109 -76.75 -96.17 18 A GLN 110 -170.95 147.00 18 A GLU 114 -73.20 -70.90 18 A TYR 128 -64.11 2.79 18 A SER 129 -81.65 47.05 18 A LYS 130 -92.35 -111.82 19 A ALA 2 -163.16 -94.10 19 A ALA 4 -162.50 28.37 19 A LYS 6 -93.04 31.11 19 A GLN 12 -76.36 -70.40 19 A GLU 13 -48.64 -17.87 19 A GLU 30 -61.91 0.49 19 A ALA 39 -162.49 89.33 19 A ASP 42 -157.25 35.09 19 A THR 44 -82.17 -141.96 19 A PHE 59 -85.19 -74.01 19 A THR 67 -92.77 36.74 19 A LYS 88 -47.41 -18.00 19 A ARG 89 -85.35 -72.02 19 A TRP 95 -56.14 -9.84 19 A LEU 97 -59.81 -1.66 19 A ALA 98 -83.30 -71.48 19 A ASN 101 -77.21 -70.88 19 A CYS 103 -164.65 67.85 19 A LYS 106 -93.88 -114.83 19 A ASP 109 -72.07 -121.57 19 A GLU 114 -72.60 -74.17 19 A LYS 130 31.57 -111.42 20 A ALA 2 -169.59 5.39 20 A ALA 4 -160.89 -7.69 20 A LYS 6 -92.79 32.16 20 A GLU 30 -62.20 0.56 20 A ILE 36 -146.76 -35.39 20 A ALA 39 -161.65 44.15 20 A LYS 41 -86.21 -90.10 20 A PHE 59 -85.24 -73.54 20 A THR 67 -93.24 46.55 20 A ARG 89 -90.02 -69.30 20 A LEU 97 -59.62 -1.49 20 A ALA 98 -79.60 -72.55 20 A CYS 103 -165.07 67.79 20 A LYS 106 -92.22 -115.12 20 A ALA 108 -172.27 -164.66 20 A ASP 109 -83.28 -127.62 20 A GLU 114 -69.30 -75.74 20 A TYR 128 -76.78 21.51 20 A LYS 130 -157.19 -150.27 20 A CYS 131 -47.05 -15.90 20 A SER 132 -79.64 35.95 21 A GLU 3 -171.16 94.52 21 A ALA 4 -171.33 107.76 21 A LYS 6 -160.96 8.80 21 A ASP 35 -51.03 170.61 21 A ILE 36 -146.92 -34.93 21 A LYS 41 -91.09 -82.37 21 A PHE 59 -85.09 -70.18 21 A HIS 62 -90.29 -61.18 21 A THR 67 -76.00 39.47 21 A ARG 68 -79.97 -76.86 21 A CYS 69 -95.97 30.65 21 A ALA 72 -146.91 -35.72 21 A ARG 89 -89.44 -77.14 21 A TRP 95 -48.61 -14.11 21 A ALA 98 -88.03 -75.73 21 A CYS 103 -165.03 68.12 21 A LYS 106 -141.16 -107.33 21 A ALA 108 175.51 177.84 21 A ASP 109 -83.99 -107.79 21 A GLN 110 -171.17 145.53 21 A GLU 114 -72.14 -74.95 21 A LYS 130 -169.81 -134.75 21 A CYS 131 -74.88 27.15 21 A SER 132 -156.83 87.03 22 A GLU 3 -170.58 75.83 22 A HIS 5 -147.63 -156.23 22 A LYS 6 -147.67 26.82 22 A GLU 30 -52.34 -9.50 22 A ALA 39 -164.70 46.01 22 A LYS 41 -147.79 -86.97 22 A PHE 59 -85.17 -73.56 22 A THR 67 -94.08 39.52 22 A ARG 68 -90.79 -60.63 22 A LEU 70 -95.29 -71.29 22 A THR 73 -47.14 152.91 22 A ARG 89 -90.12 -73.54 22 A LEU 97 -59.75 -1.56 22 A ALA 98 -81.10 -70.54 22 A ASN 101 -90.96 -69.75 22 A CYS 103 -164.83 68.05 22 A LYS 106 -92.19 -117.29 22 A ALA 108 173.12 -177.92 22 A ASP 109 -77.98 -119.39 22 A TYR 128 -68.45 8.53 22 A LYS 130 -164.13 -101.90 22 A SER 132 -95.76 -155.39 23 A ALA 4 -63.63 -90.49 23 A HIS 5 -59.79 -155.21 23 A LYS 6 -144.23 38.55 23 A LYS 25 -151.30 82.14 23 A CYS 28 -65.46 4.41 23 A ILE 36 -144.76 -35.27 23 A ALA 39 -164.03 33.09 23 A LYS 41 -148.41 -84.26 23 A THR 44 -70.83 -157.55 23 A PHE 59 -85.06 -71.71 23 A THR 67 -92.43 47.99 23 A ALA 72 -165.82 -34.50 23 A THR 73 -60.04 -179.91 23 A ARG 89 -79.18 -72.32 23 A LEU 90 -57.38 -5.53 23 A LEU 97 -59.58 -1.37 23 A ALA 98 -81.13 -73.26 23 A ASN 101 -92.59 -66.05 23 A CYS 103 -157.88 67.97 23 A LYS 106 -92.31 -130.08 23 A ALA 108 170.08 140.37 23 A ASP 109 -71.08 -126.37 23 A LYS 130 -171.41 -152.27 23 A CYS 131 -48.62 -14.64 23 A SER 132 -87.48 36.05 24 A ALA 2 -148.93 29.80 24 A GLU 30 -55.98 -9.55 24 A LEU 31 -69.07 -173.62 24 A ILE 36 -147.35 -35.10 24 A ALA 39 -149.78 26.15 24 A LYS 41 -147.21 -42.06 24 A ASP 42 -146.74 10.98 24 A PHE 59 -85.03 -71.14 24 A THR 67 -86.51 46.31 24 A ARG 68 -95.49 -61.95 24 A ALA 72 -147.38 -35.13 24 A THR 73 -50.47 175.66 24 A LYS 88 -48.54 -16.87 24 A ARG 89 -87.39 -75.02 24 A TRP 95 -48.45 -14.35 24 A LEU 97 -59.87 -1.54 24 A ALA 98 -83.70 -72.57 24 A ASN 101 -72.21 -75.39 24 A CYS 103 -164.95 68.25 24 A LYS 106 -92.59 -107.15 24 A ASP 109 -88.68 -111.32 24 A GLU 114 -71.66 -76.88 24 A LYS 130 -171.01 -153.58 24 A CYS 131 -48.61 -19.86 24 A SER 132 -90.47 36.07 25 A ALA 2 -54.90 -171.26 25 A ALA 4 -178.07 -31.11 25 A LYS 6 -75.66 39.29 25 A CYS 28 -59.73 -4.08 25 A LEU 31 -60.19 -171.47 25 A ALA 39 -162.00 89.11 25 A LYS 41 -137.70 -82.50 25 A THR 43 -69.90 -179.97 25 A PHE 59 -85.08 -72.55 25 A THR 67 -93.90 42.28 25 A ARG 89 -85.78 -73.60 25 A LEU 94 -56.96 -71.14 25 A LEU 97 -59.77 -1.55 25 A ALA 98 -80.89 -73.08 25 A ASN 101 -92.45 -70.18 25 A CYS 103 -162.31 68.24 25 A LYS 106 -93.02 -119.48 25 A ASP 109 -92.53 -116.93 25 A GLU 114 -68.63 -77.38 25 A LYS 130 -175.69 -114.24 26 A ALA 2 -162.86 54.43 26 A CYS 28 -66.82 6.66 26 A ALA 38 -61.94 0.34 26 A ALA 39 -164.36 62.54 26 A LYS 41 -153.15 -83.80 26 A PHE 59 -85.12 -71.35 26 A GLU 64 -47.37 -16.15 26 A THR 67 -90.61 47.15 26 A ALA 72 -148.63 -37.04 26 A ARG 89 -85.37 -72.17 26 A LEU 97 -59.66 -1.40 26 A ALA 98 -78.38 -71.95 26 A ASN 101 -92.96 -71.08 26 A CYS 103 -161.11 68.00 26 A LYS 106 -92.70 -130.09 26 A ALA 108 170.01 159.19 26 A ASP 109 -93.14 -122.27 26 A GLU 114 -65.04 -73.49 26 A LYS 130 -175.35 -114.89 26 A SER 132 -87.26 35.95 27 A GLU 3 -161.39 -95.30 27 A ALA 4 -155.72 -28.83 27 A HIS 5 -69.74 95.95 27 A CYS 28 -64.23 3.08 27 A ALA 39 -164.87 19.98 27 A LYS 41 -145.07 -90.41 27 A PHE 59 -84.97 -71.56 27 A THR 67 -93.12 41.11 27 A ALA 72 -147.82 -35.33 27 A THR 73 -49.76 154.76 27 A ARG 89 -77.07 -70.73 27 A LEU 97 -59.61 -1.58 27 A ALA 98 -82.58 -74.05 27 A ASN 101 -93.01 -63.95 27 A CYS 103 -165.02 68.24 27 A LYS 106 -92.47 -114.54 27 A ALA 108 -178.86 -169.97 27 A ASP 109 -86.83 -123.60 27 A LYS 130 -147.43 -144.20 28 A ALA 2 -177.33 -94.67 28 A HIS 5 -55.64 -169.83 28 A LYS 6 -157.51 0.66 28 A CYS 28 -58.95 -4.36 28 A ASP 35 -49.84 168.78 28 A ILE 36 -146.33 -34.78 28 A LYS 41 -139.27 -77.86 28 A PHE 59 -85.05 -72.39 28 A GLU 64 -47.38 -18.79 28 A THR 67 -92.48 44.71 28 A LEU 70 -94.36 -64.12 28 A ARG 89 -85.69 -72.10 28 A LEU 94 -53.43 -71.56 28 A TRP 95 -49.46 -12.86 28 A LEU 97 -59.78 -1.65 28 A CYS 103 -165.01 68.11 28 A LYS 106 -81.07 -122.70 28 A ASP 109 -92.68 -111.47 28 A GLU 114 -70.64 -79.55 28 A LYS 130 -175.21 -114.82 28 A SER 132 -91.91 36.24 29 A ALA 2 -157.61 13.14 29 A ALA 4 -164.90 107.43 29 A THR 26 -92.90 -152.62 29 A LEU 31 -61.50 -169.85 29 A ALA 39 -159.82 45.69 29 A ASP 42 -149.55 24.44 29 A PHE 59 -83.83 -70.03 29 A THR 67 -76.70 36.94 29 A ALA 72 -147.35 -35.13 29 A THR 73 -54.32 171.11 29 A ARG 89 -80.35 -72.01 29 A LEU 97 -59.84 -1.39 29 A ASN 101 -92.55 -63.61 29 A CYS 103 -164.97 68.24 29 A LYS 106 -139.09 -127.60 29 A ALA 108 179.80 -170.24 29 A ASP 109 -78.99 -130.86 29 A GLU 114 -74.29 -72.67 29 A TYR 128 -67.36 4.78 29 A SER 129 -74.42 22.17 29 A LYS 130 -75.92 -104.93 29 A SER 132 -95.77 -155.47 30 A ALA 2 -166.87 -168.34 30 A ALA 4 -177.62 -28.22 30 A LYS 6 -63.50 2.05 30 A GLU 30 -57.03 -5.55 30 A LYS 41 -136.99 -46.16 30 A ASP 42 -93.49 31.17 30 A THR 44 -92.57 -139.11 30 A THR 67 -87.94 44.35 30 A ARG 68 -99.71 -60.74 30 A ALA 72 -147.37 -35.55 30 A THR 73 -69.73 -179.09 30 A LEU 94 -48.39 -72.12 30 A ASN 101 -92.21 -90.36 30 A CYS 103 -164.97 68.10 30 A LYS 106 -92.85 -128.73 30 A ALA 108 -154.53 -153.50 30 A ASP 109 -91.42 -126.63 30 A GLU 114 -68.83 -76.93 30 A TYR 128 -64.83 3.70 30 A LYS 130 -174.88 -114.41 31 A ALA 2 -160.85 -8.87 31 A GLU 3 -64.83 -92.34 31 A HIS 5 -146.46 57.01 31 A CYS 28 -64.67 0.62 31 A LEU 31 -60.98 -172.43 31 A ALA 39 -148.17 36.73 31 A LYS 41 -149.43 -88.74 31 A THR 44 -84.23 -136.53 31 A ARG 57 -62.86 -71.95 31 A PHE 59 -81.13 -72.57 31 A THR 67 -77.48 48.12 31 A ARG 68 -97.69 -66.00 31 A ALA 72 -147.75 -35.32 31 A THR 73 -69.81 -179.51 31 A LEU 97 -59.46 -2.24 31 A CYS 103 -165.02 68.20 31 A LYS 106 -92.57 -114.10 31 A ASP 109 -90.72 -120.19 31 A GLU 114 -73.14 -78.81 31 A TYR 128 -66.21 5.52 31 A LYS 130 -157.20 -102.01 31 A SER 132 -84.26 37.12 THE HIGH RESOLUTION THREE-DIMENSIONAL SOLUTION STRUCTURE OF HUMAN INTERLEUKIN-4 DETERMINED BY MULTI-DIMENSIONAL HETERONUCLEAR MAGNETIC RESONANCE SPECTROSCOPY 1 Y N A ASP 8 A ASP 8 HELX_P A GLN 24 A GLN 24 1 1 17 A THR 26 A THR 26 HELX_P A GLU 30 A GLU 30 5 2 5 A ILE 36 A ILE 36 HELX_P A SER 40 A SER 40 5 3 5 A THR 44 A THR 44 HELX_P A HIS 63 A HIS 63 1 4 20 A THR 73 A THR 73 HELX_P A GLY 99 A GLY 99 1 5 27 A LEU 113 A LEU 113 HELX_P A TYR 128 A TYR 128 1 6 16 disulf 2.021 A CYS 7 A SG CYS 7 1_555 A CYS 131 A SG CYS 131 1_555 disulf 2.020 A CYS 28 A SG CYS 28 1_555 A CYS 69 A SG CYS 69 1_555 disulf 2.021 A CYS 50 A SG CYS 50 1_555 A CYS 103 A SG CYS 103 1_555 CYTOKINE INTERLEUKIN-4, CYTOKINE IL4_HUMAN UNP 1 1 P05112 MGLTSQLLPPLFFLLACAGNFVHGHKCDITLQEIIKTLNSLTEQKTLCTELTVTDIFAASKNTTEKETFCRAATVLRQFY SHHEKDTRCLGATAQQFHRHKQLIRFLKRLDRNLWGLAGLNSCPVKEANQSTLENFLERLKTIMREKYSKCSS 25 153 1ITI 5 133 P05112 A 1 5 133 1 ASN conflict ASP 42 1ITI A P05112 UNP 62 42 1 ASN conflict ASP 109 1ITI A P05112 UNP 129 109 2 anti-parallel A THR 32 A THR 32 A VAL 33 A VAL 33 A SER 111 A SER 111 A THR 112 A THR 112 1 P 1